Navigation Links
IlluminOss(TM) Photodynamic Bone Stabilization System Receives CE Mark
Date:3/23/2009

Allows Commercialization in the European Union

EAST PROVIDENCE, R.I., March 23 /PRNewswire/ -- IlluminOss Medical Inc., a medical device company developing the innovative IlluminOss(TM) Photodynamic Bone Stabilization System for orthopedic surgery, today announced that it had been granted a CE Mark. The approval permits the Company to market this product in the European Union (EU).

IlluminOss Medical is beginning the process of selecting distribution partners in the EU for the IlluminOss Photodynamic Bone Stabilization System.

With traditional methods of treating fractures, often a large incision has to be made; and plates and screws inserted to stabilize the fracture. There may be extensive soft tissue damage; the patient has limited or no mobility initially which may lead to temporary or permanent stiffness; and the patient may experience severe pain.

The IlluminOss Photodynamic Bone Stabilization System requires just a small 4.5mm pathway into the bone to stabilize it. A small diameter balloon catheter and light fiber are inserted into the intramedullary canal of the bone. A photo sensitive, liquid monomer is then infused into the balloon. The monomer expands the balloon to fit the contours of the interior of the bone, aiding in the reduction of the fracture. Then the light source is activated, converting the liquid monomer into a hardened polymer within 90 seconds. The minimal skin incision is then closed.

Unlike other methods of fracture treatment, the IlluminOss Photodynamic Bone Stabilization System is designed to enable the patient to have immediate joint mobility post procedure without the need for immobilization. Due to the minimally invasive approach, soft tissue injury is virtually eliminated. Having immediate mobility minimizes the potential for tendon adhesions and a tenolysis procedure to remove them.

According to Bob Rabiner, Founder and CEO of IlluminOss Medical, "This approval represents a major milestone for IlluminOss and patients in the EU. We believe that our minimally invasive technology will fundamentally improve the treatment of hundreds of thousands of bone fractures by driving much earlier restoration of functionality, improving the durability of orthopedic repairs, decreasing pain and reducing scarring."

About IlluminOss Medical Inc.

IlluminOss Medical is a privately held, early-stage medical device company dedicated to the development of minimally invasive orthopedic systems for the stabilization and treatment of bone fractures. The IlluminOss Photodynamic Bone Stabilization System utilizes a photodynamic (light-curable) polymer system intended to eliminate the need for traditional, inconvenient and painful methods of bone fixation with external pins, plates and screws. The Company is currently developing the IlluminOss Photodynamic Bone Stabilization System for small bones such as fractures of the hands, wrists, clavicle and arms. It is anticipated that the IlluminOss Photodynamic Bone Stabilization System will also have applications in the spine and long bones.

Founded in 2007, IlluminOss is headquartered in East Providence, RI. For more information about IlluminOss Medical, please visit www.illuminoss.com.

    Company Contact:                             Media Contact:
    Bob Rabiner                                  Stephen Sandler
    (401) 714-0008 ext. 207                      (508) 358-7206 ext. 202
    rrabiner@illuminoss.com                      ssandler@vmark.net


'/>"/>
SOURCE IlluminOss Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology
2. Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients
3. NJHA: Hospital Needs Exceed Stabilization Fund Resources
4. Scientx Announces FDA 510(K) Clearance for Isobar DUO(TM) Dynamic Stabilization System
5. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
6. Healthcare Tech and the World: Advancing Autonomy in the UK Healthcare System
7. U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System
8. Orcas Family Health Center Installs First Ultrasound System on Island
9. Thus I Became Stress Free, Oh Really?: Systematically Manage and Optimize Stress to Improve Productivity, Happiness
10. MTM Upgrades its Phone System to Ensure Leading edge Technology and Software Feature sets for Existing and Future Clients
11. University HealthSystem Consortium Selects KONE to Provide Elevator Maintenance Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official ... NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in ... from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... Cure’s campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s ... smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , ...
(Date:2/5/2016)... ... ... Dr. Justin Scott and Dr. Lydia Muccioli of Pure Dental Health ... need. The event is scheduled to take place on February 27, 2016 from 9am ... care to community members in need. Each patient will be given the opportunity to ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the ... a dream. A hallmark feature of patients with eating disorders is significant self-criticism, and ... disorder behaviors and obsessions are regarded as maladaptive means for coping with this unease, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Calls Blacklist has just been updated by ... design and the developer has fixed known bugs within the app. Calls Blacklist allows ... phone while not consuming any of their device’s battery power or memory. It provides ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Wegener ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline ... Wegener Polyangiitis,s therapeutic pipeline. This report provides ... Polyangiitis, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... In response to the opioid abuse epidemic, today ... Medical Products and Tobacco, along with other FDA leaders, called ... to opioid medications. The plan will focus on policies aimed ... access to effective relief. --> ... the risk-benefit paradigm for opioids and ensure that the agency ...
Breaking Medicine Technology: